Business
HARMONY BIOSCIENCES PRESIDENT & CEO JEFFREY M. DAYNO, M.D., NAMED TO 2023 PHARMAVOICE 100 LIST OF TOP INDUSTRY LEADERS
The list recognizes the most inspiring and transformative life sciences leaders driving positive impact at their companies, within their industry, and on
About this update from Harmony Biosciences Holdings, Inc.
[{"type":"text","content":"The list recognizes the most inspiring and transformative life sciences leaders driving positive impact at their companies, within their industry, and on behalf of the patients they serve\n\n\nPLYMOUTH MEETING, Pa., Sept. 20, 2023 /PRNewswire/ -- Jeffrey M. Dayno, M.D., President & CEO of Harmony Biosciences, was named to the 2023 PharmaVoice 100 list for his unwavering commitment to bring clinical innovation and hope to patients living with rare neurological diseases. Harmony Biosciences Holdings, Inc. (\"Harmony\") (Nasdaq: HRMY) is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases.\n\n \n \n \n \n \n \n\n \nEstablished in 2005, the PharmaVoice 100 list honors and highlights a diverse mix of noteworthy, influential executives – from the clinic to the C-suite – making important contributions to the life sciences sector and inspiring meaningful change in support of patients globally.\n\"I am honored and humbled to be selected for this prestigious recognition and to share this platform with an extraordinary group of transformative leaders in life sciences. Throughout my career, I have been fortunate to be mentored by exceptional leaders and to work alongside many talented professionals. These relationships have helped to shape my leadership style and afforded me the opportunity to advance my career, while mentoring the next generation of life sciences leaders,\" said Dr. Dayno. \"At Harmony Biosciences, we believe that where empathy and innovation meet, a better life can begin for patients living with neurological diseases. I am energized by the incredible talent across our organization and proud to lead this team of dedicated individuals, as we strive to develop and commercialize innovative treatments to bring hope to patients living with unmet medical needs.\"\nA former practicing neurologist and faculty member at Jefferson Medical College, Dr. Dayno brought his experience at the bedside to the industry 25 years ago and has held various leadership positions since then. He has been involved in multiple NDA approvals and has built and led medical teams that have collaborated with commercial teams in support of several successful drug launches. Dr. Dayno joined Harmony Biosciences in 2017 as the company's first Chief Medical Officer and was appoin...